8-K: Kairos Pharma, LTD. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-11-03 AccNo: 0001493152-26-049744 Size: 10 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financia
Filed: 2026-11-03 AccNo: 0001493152-26-049744 Size: 10 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financia